相关实验视频

Updated: Aug 6, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

DSPE-mPEG2000-修改型 podophyllotoxin 长循环脂质体用于有针对性的输送:它们的制备,表征和评估

Langlang Zhang¹, Rongyu Li¹, Han Zhang²

¹Department of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.

Current drug delivery

|January 6, 2025

概括

用DSPE-mPEG2000修改的长循环 podophyllotoxin 脂质体 (Lc-PTOX-Lps) 显示出增强的稳定性,延长的循环,并改善了抗癌效果,对 MCF-7 细胞的毒性降低. 这种简单的方法产生了有前途的抗癌剂.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
药理学药理学是指药理学的学科.

背景情况:

像DSPE-mPEG2000这样的脂-聚乙烯甘醇结合物对于药物递送系统至关重要,增强脂质体稳定性和药物疗效.
DSPE-mPEG2000的两性质使其能够形成稳定的脂质体结构,改善药物封装和受控释放.

研究的目的:

通过使用DSPE-mPEG2000.使用DSPE-mPEG2000.合成和表征长循环的 podophyllotoxin 脂质体 (Lc-PTOX-Lps).
评估Lc-PTOX-Lps.的药理动力学特征和体外抗癌活性.

主要方法:

使用DSPE-mPEG2000作为表面修饰剂制备Lc-PTOX-Lps.
脂质体属性的表征,包括封装速率,颗粒大小,多分散度指数和泽塔潜力.
在体外释放药物的研究,药物动力学分析,以及对MCF-7细胞抗癌作用的评估.

主要成果:

Lc-PTOX-Lps表现出高封装效率 (87.11±1.77%) 和最佳颗粒大小 (168.91±7.07 nm).
与免费药物相比,脂质体表现出持续的药物释放,改善的稳定性,延长的半衰期,减少的清除和增强的生物可用性.
观察到对MCF-7细胞具有显著的抗癌活性,同时对正常细胞的毒性较低.

结论:

开发了一种简单有效的方法来合成DSPE-mPEG2000-修改的LC-PTOX-Lps.
这些Lc-PTOX-Lps代表了抗癌药物输送的有前途的纳米载体,提供了更好的治疗潜力.

关键词:

癌症治疗治疗癌症治疗在 DSPE-mPEG2000 中使用.药理动力学药理动力学波多菲洛托克辛 (podophyllotoxin) 是一种可怕的毒素.脂质体是一种脂质体.

更多相关视频

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...